VaryScreen I Performs Multiple Assay Types on a Single WorkcellVaryScreen I Performs Multiple Assay Types on a Single Workcell
Springfield, NJ (January 25, 2009) – Hudson Control Group, Inc., a leader in microplate automation, robotics and customized software-driven solutions, introduced VaryScreen™ I, a versatile multi-assay screening and development system, at the LabAutomation2009 exhibition, opening today at the Palm Springs Convention Center, Palm Springs, CA. VaryScreen I is on display in Booth 415.
“VaryScreen will appeal to the wide range of customers who want a workcell that handles a greater number of assays, instead of dedicating a system to one assay type,” said Phil Farrelly, president of Hudson Control Group. “VaryScreen delivers the freedom and flexibility not only to conduct many assay types on a single workcell, but to model changes within assays, which is critical to validating assays in real time.”
Targeted at applications from drug discovery to genomics and proteomics, in environments from research to high throughput screening, VaryScreen now enables investigators to rapidly switch assays, including six of the most commonly performed assays today:
- Fluorescence Polarization
- UV/Vis Absorbance
Users can perform countless other assays with just a few user-friendly software modifications. And they can make and analyze changes within assay types to develop, model and validate in-house screens – all on a single system.
See the VaryScreen at LabAutomation2009, Booth 415. For information or to arrange a demonstration, please visit www.hudsoncontrol.com.
About Lab Automation
LabAutomation2009, presented by the Association for Laboratory Automation (ALA), is the world’s largest conference and exhibition focused exclusively on the rapidly growing field of laboratory automation.
About Hudson Control Group
Located in Springfield, New Jersey, Hudson Control Group is a leader in microplate automation, robotics and customized software-driven solutions. The company works with customers in the drug discovery, high-throughput screening, proteomics and genomics markets to develop strategies that best meet their unique needs, whether for an integrated system of automated laboratory equipment or for automating a single instrument.